RG
AMGN icon

Redmile Group’s Amgen AMGN Stock Holding History

Redmile Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-163,254
Closed -$19.3M – 56
2014
Q2 		$19.3M Buy
+163,254
New +$18.9M 2.34% 20
2013
Q4 		– Sell
-345,700
Closed -$38.7M – 58
2013
Q3 		$38.7M Buy
+345,700
New +$37.5M 5.83% 2

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Redmile Group's AMGN Position: Q3 2014 in Review

Redmile Group sold out of Amgen (AMGN) in Q3 2014, closing a stake of 163,254 shares — an estimated $19.3M sold.

Redmile Group first reported a position in AMGN in Q3 2013 and held it in 2 quarters. The position peaked at $38.7M in Q3 2013. 1,223 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.

  • Redmile Group reported no remaining Amgen position as of Q3 2014 after selling out during the quarter.
  • Redmile Group sold 163,254 Amgen shares in Q3 2014, an estimated $19.3M.
  • Redmile Group first reported a position in Amgen in Q3 2013 and held it in 2 quarters.
  • Redmile Group's Amgen position peaked at $38.7M in Q3 2013.
  • 1,223 funds tracked by Wall St. Rank held Amgen as of Q3 2014.

Based on Redmile Group's 13F filing for Q3 2014, filed 14 Nov 2014.